Loading…

Oxaliplatin-induced haemolytic anaemia

A case of haemolytic anaemia after therapy with oxaliplatin, an anticancer chemotherapeutic agent, was investigated. Haemolytic anaemia has been associated with cisplatin and carboplatin, two related drugs, but not with oxaliplatin.

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 1999-10, Vol.354 (9185), p.1179-1180
Main Authors: Desrame, J, Broustet, H, de Tailly, P Darodes, Girard, D, Saissy, JM
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c414t-38328a34b755e3612924cb3fd936bac9467c4e9f50511b7fbc6695275be949cc3
cites cdi_FETCH-LOGICAL-c414t-38328a34b755e3612924cb3fd936bac9467c4e9f50511b7fbc6695275be949cc3
container_end_page 1180
container_issue 9185
container_start_page 1179
container_title The Lancet (British edition)
container_volume 354
creator Desrame, J
Broustet, H
de Tailly, P Darodes
Girard, D
Saissy, JM
description A case of haemolytic anaemia after therapy with oxaliplatin, an anticancer chemotherapeutic agent, was investigated. Haemolytic anaemia has been associated with cisplatin and carboplatin, two related drugs, but not with oxaliplatin.
doi_str_mv 10.1016/S0140-6736(99)03827-1
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2069951695</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0140673699038271</els_id><sourcerecordid>45506268</sourcerecordid><originalsourceid>FETCH-LOGICAL-c414t-38328a34b755e3612924cb3fd936bac9467c4e9f50511b7fbc6695275be949cc3</originalsourceid><addsrcrecordid>eNqF0E1LwzAYwPEgipvTj6AMFdFDNU_z1pxEhm8w2EEFbyFNU8zo2pm04r692QvqRTwlh9_zJPwROgR8CRj41RMGihMuCD-X8gKTLBUJbKE-UEETRsXrNup_kx7aC2GKMaYcs13UA8yACMj66GzyqSs3r3Tr6sTVRWdsMXzTdtZUi9aZoa7j3el9tFPqKtiDzTlAL3e3z6OHZDy5fxzdjBNDgbYJyUiaaUJzwZglHFKZUpOTspCE59pIyoWhVpYsvg-5KHPDuWSpYLmVVBpDBuhkvXfum_fOhlZNm87X8UmVYi4lg-ijOv5LgZQYp5xCRGyNjG9C8LZUc-9m2i8UYLVMqFYJ1bKPklKtEqrl3NFmeZfPbPFrat0sgtMN0MHoqvS6Ni78OMk5zWhk12tmY68PZ70Kxtk69nXemlYVjfvnJ19ee4oc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>199002641</pqid></control><display><type>article</type><title>Oxaliplatin-induced haemolytic anaemia</title><source>Elsevier</source><source>BSC - Ebsco (Business Source Ultimate)</source><creator>Desrame, J ; Broustet, H ; de Tailly, P Darodes ; Girard, D ; Saissy, JM</creator><creatorcontrib>Desrame, J ; Broustet, H ; de Tailly, P Darodes ; Girard, D ; Saissy, JM</creatorcontrib><description>A case of haemolytic anaemia after therapy with oxaliplatin, an anticancer chemotherapeutic agent, was investigated. Haemolytic anaemia has been associated with cisplatin and carboplatin, two related drugs, but not with oxaliplatin.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(99)03827-1</identifier><identifier>PMID: 10513718</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>Adenocarcinoma - drug therapy ; Adenocarcinoma - secondary ; Aged ; Anemia ; Anemia, Hemolytic - chemically induced ; Anticancer properties ; Antineoplastic Agents - adverse effects ; Antineoplastic Agents - blood ; Back pain ; Biological and medical sciences ; Blood ; Carboplatin ; Chemotherapy ; Cisplatin ; Colorectal Neoplasms - pathology ; Drug therapy ; Drug toxicity and drugs side effects treatment ; Fatal Outcome ; Female ; Hemolytic anemia ; Humans ; Liver Neoplasms - drug therapy ; Liver Neoplasms - secondary ; Medical research ; Medical sciences ; Organoplatinum Compounds - adverse effects ; Organoplatinum Compounds - blood ; Oxaliplatin ; Pharmacology. Drug treatments ; Prescription drugs ; Toxicity: blood</subject><ispartof>The Lancet (British edition), 1999-10, Vol.354 (9185), p.1179-1180</ispartof><rights>1999 Elsevier Ltd</rights><rights>1999 INIST-CNRS</rights><rights>Copyright Lancet Ltd. Oct 2, 1999</rights><rights>Copyright Elsevier Limited Oct 2, 1999</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c414t-38328a34b755e3612924cb3fd936bac9467c4e9f50511b7fbc6695275be949cc3</citedby><cites>FETCH-LOGICAL-c414t-38328a34b755e3612924cb3fd936bac9467c4e9f50511b7fbc6695275be949cc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1966484$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10513718$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Desrame, J</creatorcontrib><creatorcontrib>Broustet, H</creatorcontrib><creatorcontrib>de Tailly, P Darodes</creatorcontrib><creatorcontrib>Girard, D</creatorcontrib><creatorcontrib>Saissy, JM</creatorcontrib><title>Oxaliplatin-induced haemolytic anaemia</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>A case of haemolytic anaemia after therapy with oxaliplatin, an anticancer chemotherapeutic agent, was investigated. Haemolytic anaemia has been associated with cisplatin and carboplatin, two related drugs, but not with oxaliplatin.</description><subject>Adenocarcinoma - drug therapy</subject><subject>Adenocarcinoma - secondary</subject><subject>Aged</subject><subject>Anemia</subject><subject>Anemia, Hemolytic - chemically induced</subject><subject>Anticancer properties</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>Antineoplastic Agents - blood</subject><subject>Back pain</subject><subject>Biological and medical sciences</subject><subject>Blood</subject><subject>Carboplatin</subject><subject>Chemotherapy</subject><subject>Cisplatin</subject><subject>Colorectal Neoplasms - pathology</subject><subject>Drug therapy</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Fatal Outcome</subject><subject>Female</subject><subject>Hemolytic anemia</subject><subject>Humans</subject><subject>Liver Neoplasms - drug therapy</subject><subject>Liver Neoplasms - secondary</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Organoplatinum Compounds - adverse effects</subject><subject>Organoplatinum Compounds - blood</subject><subject>Oxaliplatin</subject><subject>Pharmacology. Drug treatments</subject><subject>Prescription drugs</subject><subject>Toxicity: blood</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqF0E1LwzAYwPEgipvTj6AMFdFDNU_z1pxEhm8w2EEFbyFNU8zo2pm04r692QvqRTwlh9_zJPwROgR8CRj41RMGihMuCD-X8gKTLBUJbKE-UEETRsXrNup_kx7aC2GKMaYcs13UA8yACMj66GzyqSs3r3Tr6sTVRWdsMXzTdtZUi9aZoa7j3el9tFPqKtiDzTlAL3e3z6OHZDy5fxzdjBNDgbYJyUiaaUJzwZglHFKZUpOTspCE59pIyoWhVpYsvg-5KHPDuWSpYLmVVBpDBuhkvXfum_fOhlZNm87X8UmVYi4lg-ijOv5LgZQYp5xCRGyNjG9C8LZUc-9m2i8UYLVMqFYJ1bKPklKtEqrl3NFmeZfPbPFrat0sgtMN0MHoqvS6Ni78OMk5zWhk12tmY68PZ70Kxtk69nXemlYVjfvnJ19ee4oc</recordid><startdate>19991002</startdate><enddate>19991002</enddate><creator>Desrame, J</creator><creator>Broustet, H</creator><creator>de Tailly, P Darodes</creator><creator>Girard, D</creator><creator>Saissy, JM</creator><general>Elsevier Ltd</general><general>Lancet</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TT</scope><scope>0TZ</scope><scope>0U~</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KB~</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope></search><sort><creationdate>19991002</creationdate><title>Oxaliplatin-induced haemolytic anaemia</title><author>Desrame, J ; Broustet, H ; de Tailly, P Darodes ; Girard, D ; Saissy, JM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c414t-38328a34b755e3612924cb3fd936bac9467c4e9f50511b7fbc6695275be949cc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adenocarcinoma - drug therapy</topic><topic>Adenocarcinoma - secondary</topic><topic>Aged</topic><topic>Anemia</topic><topic>Anemia, Hemolytic - chemically induced</topic><topic>Anticancer properties</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>Antineoplastic Agents - blood</topic><topic>Back pain</topic><topic>Biological and medical sciences</topic><topic>Blood</topic><topic>Carboplatin</topic><topic>Chemotherapy</topic><topic>Cisplatin</topic><topic>Colorectal Neoplasms - pathology</topic><topic>Drug therapy</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Fatal Outcome</topic><topic>Female</topic><topic>Hemolytic anemia</topic><topic>Humans</topic><topic>Liver Neoplasms - drug therapy</topic><topic>Liver Neoplasms - secondary</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Organoplatinum Compounds - adverse effects</topic><topic>Organoplatinum Compounds - blood</topic><topic>Oxaliplatin</topic><topic>Pharmacology. Drug treatments</topic><topic>Prescription drugs</topic><topic>Toxicity: blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Desrame, J</creatorcontrib><creatorcontrib>Broustet, H</creatorcontrib><creatorcontrib>de Tailly, P Darodes</creatorcontrib><creatorcontrib>Girard, D</creatorcontrib><creatorcontrib>Saissy, JM</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>News PRO</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Global News &amp; ABI/Inform Professional</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Newsstand Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database (Proquest)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>ProQuest Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Desrame, J</au><au>Broustet, H</au><au>de Tailly, P Darodes</au><au>Girard, D</au><au>Saissy, JM</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oxaliplatin-induced haemolytic anaemia</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>1999-10-02</date><risdate>1999</risdate><volume>354</volume><issue>9185</issue><spage>1179</spage><epage>1180</epage><pages>1179-1180</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><abstract>A case of haemolytic anaemia after therapy with oxaliplatin, an anticancer chemotherapeutic agent, was investigated. Haemolytic anaemia has been associated with cisplatin and carboplatin, two related drugs, but not with oxaliplatin.</abstract><cop>London</cop><pub>Elsevier Ltd</pub><pmid>10513718</pmid><doi>10.1016/S0140-6736(99)03827-1</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0140-6736
ispartof The Lancet (British edition), 1999-10, Vol.354 (9185), p.1179-1180
issn 0140-6736
1474-547X
language eng
recordid cdi_proquest_journals_2069951695
source Elsevier; BSC - Ebsco (Business Source Ultimate)
subjects Adenocarcinoma - drug therapy
Adenocarcinoma - secondary
Aged
Anemia
Anemia, Hemolytic - chemically induced
Anticancer properties
Antineoplastic Agents - adverse effects
Antineoplastic Agents - blood
Back pain
Biological and medical sciences
Blood
Carboplatin
Chemotherapy
Cisplatin
Colorectal Neoplasms - pathology
Drug therapy
Drug toxicity and drugs side effects treatment
Fatal Outcome
Female
Hemolytic anemia
Humans
Liver Neoplasms - drug therapy
Liver Neoplasms - secondary
Medical research
Medical sciences
Organoplatinum Compounds - adverse effects
Organoplatinum Compounds - blood
Oxaliplatin
Pharmacology. Drug treatments
Prescription drugs
Toxicity: blood
title Oxaliplatin-induced haemolytic anaemia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T23%3A48%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oxaliplatin-induced%20haemolytic%20anaemia&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Desrame,%20J&rft.date=1999-10-02&rft.volume=354&rft.issue=9185&rft.spage=1179&rft.epage=1180&rft.pages=1179-1180&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/10.1016/S0140-6736(99)03827-1&rft_dat=%3Cproquest_cross%3E45506268%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c414t-38328a34b755e3612924cb3fd936bac9467c4e9f50511b7fbc6695275be949cc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=199002641&rft_id=info:pmid/10513718&rfr_iscdi=true